These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3135799)

  • 1. Beta-lactamase inhibitors. The inhibition of serine beta-lactamases by specific boronic acids.
    Crompton IE; Cuthbert BK; Lowe G; Waley SG
    Biochem J; 1988 Apr; 251(2):453-9. PubMed ID: 3135799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of class C beta-lactamases by boronic acids.
    Beesley T; Gascoyne N; Knott-Hunziker V; Petursson S; Waley SG; Jaurin B; Grundström T
    Biochem J; 1983 Jan; 209(1):229-33. PubMed ID: 6405733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030.
    Nguyen NQ; Krishnan NP; Rojas LJ; Prati F; Caselli E; Romagnoli C; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1760-6. PubMed ID: 26729491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible inhibitors of penicillinases.
    Kiener PA; Waley SG
    Biochem J; 1978 Jan; 169(1):197-204. PubMed ID: 415738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of "bora-penicilloates" with serine β-lactamases and DD-peptidases.
    Dzhekieva L; Adediran SA; Pratt RF
    Biochemistry; 2014 Oct; 53(41):6530-8. PubMed ID: 25302576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active sites of beta-lactamases from Bacillus cereus.
    Hill HA; Sammes PG; Waley SG
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):333-44. PubMed ID: 6109328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of the boronic acid β-lactamase inhibitor vaborbactam binding to Pseudomonas aeruginosa penicillin-binding protein 3.
    Kumar V; Viviani SL; Ismail J; Agarwal S; Bonomo RA; van den Akker F
    PLoS One; 2021; 16(10):e0258359. PubMed ID: 34653211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase(,).
    Ness S; Martin R; Kindler AM; Paetzel M; Gold M; Jensen SE; Jones JB; Strynadka NC
    Biochemistry; 2000 May; 39(18):5312-21. PubMed ID: 10820001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopenicillanic acid: kinetics.
    Loosemore MJ; Cohen SA; Pratt RF
    Biochemistry; 1980 Aug; 19(17):3990-5. PubMed ID: 6250581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase.
    Werner JP; Mitchell JM; Taracila MA; Bonomo RA; Powers RA
    Protein Sci; 2017 Mar; 26(3):515-526. PubMed ID: 27997706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boronic Acids as Prospective Inhibitors of Metallo-β-Lactamases: Efficient Chemical Reaction in the Enzymatic Active Site Revealed by Molecular Modeling.
    Krivitskaya AV; Khrenova MG
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33918209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteinyl peptide inhibitors of Bacillus cereus zinc beta-lactamase.
    Bounaga S; Galleni M; Laws AP; Page MI
    Bioorg Med Chem; 2001 Feb; 9(2):503-10. PubMed ID: 11249142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of catalysis and the inhibition of the Bacillus cereus zinc-dependent beta-lactamase.
    Bounaga S; Laws AP; Galleni M; Page MI
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):703-11. PubMed ID: 9560295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serendipitous discovery of aryl boronic acids as β-lactamase inhibitors.
    Yang SW; Pan J; Root Y; Scapin G; Xiao L; Su J
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126795. PubMed ID: 31759850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of class C beta-lactamases by (1'R,6R)-6-(1'-hydroxy)benzylpenicillanic acid SS-dioxide.
    Knight GC; Waley SG
    Biochem J; 1985 Jan; 225(2):435-9. PubMed ID: 2983675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors.
    Caselli E; Romagnoli C; Powers RA; Taracila MA; Bouza AA; Swanson HC; Smolen KA; Fini F; Wallar BJ; Bonomo RA; Prati F
    ACS Infect Dis; 2018 Mar; 4(3):337-348. PubMed ID: 29144725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.
    Caselli E; Romagnoli C; Vahabi R; Taracila MA; Bonomo RA; Prati F
    J Med Chem; 2015 Jul; 58(14):5445-58. PubMed ID: 26102369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiols as classical and slow-binding inhibitors of IMP-1 and other binuclear metallo-beta-lactamases.
    Siemann S; Clarke AJ; Viswanatha T; Dmitrienko GI
    Biochemistry; 2003 Feb; 42(6):1673-83. PubMed ID: 12578382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors.
    Sgrignani J; De Luca F; Torosyan H; Docquier JD; Duan D; Novati B; Prati F; Colombo G; Grazioso G
    J Comput Aided Mol Des; 2016 Oct; 30(10):851-861. PubMed ID: 27632226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.